Quick Answer
BIOMERICA INC reported Research And Development Expense of $1.02 million for the year ending 2025.
- BIOMERICA INC showed a decrease of -31.4% in Research And Development Expense from 2024 to 2025.
- This data is from BIOMERICA INC's annual report (Form 10-K), filed with the SEC on August 29, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), BIOMERICA INC's Research And Development Expense has grown by 143.2%.
- Historical annual values: Fiscal year 2025: $1.02 million | Fiscal year 2024: $1.49 million | Fiscal year 2023: $1.58 million | Fiscal year 2022: $1.81 million | Fiscal year 2021: $2.19 million | Fiscal year 2020: $1.91 million | Fiscal year 2019: $1.68 million | Fiscal year 2018: $1.40 million | Fiscal year 2017: $1.13 million | Fiscal year 2016: $780.3 thousand | Fiscal year 2015: $733.6 thousand | Fiscal year 2014: $589.9 thousand | Fiscal year 2013: $459.1 thousand | Fiscal year 2012: $347.1 thousand | Fiscal year 2011: $420.6 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: